NEUROPEPTIDES

1 post / 0 new
Fraser Moss
Fraser Moss's picture
NEUROPEPTIDES

October 14-16, 2009 • Chicago, USA
Satellite to the 2009 meeting of the Society for Neuroscience
NEW! UPDATED SPEAKER LIST ANNOUNCED
 
CALL FOR POSTERS
Submit abstracts now at:
www.neuropharmacology-conference.elsevier.com
 
Organized by Neuropharmacology, this satellite symposium to the 2009 meeting of the Society for Neuroscience will bring together leading experts to review and present the latest developments in our understanding of neuropeptides, their therapeutic relevance in the CNS and disease, and influence on behaviour. The conference will also look at the lessons learned from clinical trials for agents targeting key neuropeptide systems and how they will impact future translation of neuropeptide research.
 

Conference Sessions
Imaging of neuropeptidergic action in the CNS
Chair: Craig Ferris, Northeastern University, USA
Neuropeptide systems in social behaviour
Chair: Jim Goodson, Indiana University, USA
Neuropeptidergic control of stress responsivity
Chair: Inga D. Neumann, University of Regensburg, Germany
Arousal and sleep
Chair: Darryle Schoepp, Merck, USA
Emerging neuropeptide systems
Chair: Robert H. Ring, Wyeth, USA
Feeding behavior and appetite
Chair: Richard Hargreaves, Merck, USA
The role of neuropeptides in neuronal plasticity
Chair: Richard Miller, Northwestern University, USA
Neurogenic inflammation and pain
Chair: Andrew Russo, University of Iowa, USA
Lessons learned from translation
Chair: Menelas Pangalos, Wyeth, USA
Hot topics: Oral communications drawn from
contributed abstracts
Chair: David Bleakman, Eli Lilly and Co, USA
Call for Posters
To supplement the invited program, abstracts
are invited for poster presentation at the
conference. A limited number of submissions will
be selected for presentation as short oral
communications within the conference program.
Please submit abstracts now at:
www.neuropharmacology-conference.elsevier.com
by May 22, 2009.
Speakers include:
Ceri H. Davies, GlaxoSmithKline plc, UK
Marcelo Febo, Northeastern University, USA
David Feifel, University of California San Diego, USA
Craig Ferris, Northeastern University, USA
Jim Goodson, Indiana University, USA
Thomas S. Kilduff, SRI International, USA
Luis de Lecea, Stanford School of Medicine, USA
Charles Nemeroff, Emory University School of Medicine, USA
Inga D. Neumann, University of Regensburg, Germany
Hans-Christian Pape, University of Münster, Germany
Steven M. Phelps, University of Florida, USA
Frank Porreca, University of Arizona, USA
William Z. Potter, Merck, USA
Rainer K. Reinscheid, University of California Irvine, USA
Robert H. Ring, Wyeth, USA
Andrew Russo, University of Iowa, USA
Helen Scharfman, New York University, USA
Sanbing Shen, University of Aberdeen, UK
Ron Stoop, University of Lausanne, Switzerland
Ralf Stumm, Otto von Guericke University of Magdeburg, Germany
Gilles Tamagnan, Molecular Neuroimaging LLC, USA
Richmond R. Thompson, Bowdoin College Main, USA
Alexxa Veenema, University of Massachusetts, USA
Fletcher White, Loyola University of Chicago, USA
Christopher J. Winrow, Merck, USA
 
 
 

Program Committee
David Bleakman, Eli Lilly and Co, USA
Craig Ferris, Northeastern University, USA
Richard Hargreaves, Merck, USA
Richard Miller, Northwestern University, USA
Inga D. Neumann, University of Regensburg, Germany
Menelas Pangalos, Wyeth, USA
Robert H. Ring, Wyeth, USA
Darryle Schoepp, Merck, USA
 
Neuropeptides is organized, sponsored and hosted by Elsevier / Neuropharmacology and is the 19th in a series of meetings addressing key topics in neuropharmacology.

For further information please visit: www.neuropharmacology-conference.elsevier.com or contact np-conference@elsevier.com